Planet Briefing

First published · Last updated

Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies

Journal article describing integration of theoretical nitrosamine formation into translational pharmaceutics to mitigate risks during accelerated formulation development in early-phase clinical studies. Published by Elsevier BV on 2026-09-01.

Categories: science-and-space, public-health, technology

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
7/10
Urgency
2/10

Why it matters

Addresses mitigation of nitrosamine-formation risks during early-phase drug formulation, relevant to clinical development safety.

Sources

Report an issue